New directions for macrolide antibiotics: structural modifications and in vitro activity
Open Access
- 1 September 1989
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (9), 1413-1418
- https://doi.org/10.1128/aac.33.9.1413
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Susceptibility of Campylobacter pylori to macrolides and fluoroquinolonesJournal of Antimicrobial Chemotherapy, 1988
- Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in miceJournal of Antimicrobial Chemotherapy, 1988
- Hydrolysis of semi-synthetic macrolides by erythromycin esterase from Escherichia coliJournal of Antimicrobial Chemotherapy, 1988
- Comparative in-vitro activities of A-56268 (TE-031) and erythromycin against 306 clinical isolatesJournal of Antimicrobial Chemotherapy, 1988
- Prenatal Management of 746 Pregnancies at Risk for Congenital ToxoplasmosisNew England Journal of Medicine, 1988
- Comparative antimicrobial activity of the new macrolide flurithromycin against respiratory pathogensEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- In vitro Susceptibility of Mycobacterium avium to a New Macrolide (RU-28965)Chemotherapy, 1987
- Erythromycin: A Microbial and Clinical Perspective After 30 Years of Clinical Use (Second of Two Parts)Mayo Clinic Proceedings, 1985
- In-vitro evaluation of miokamycin: bactericidal activity against streptococciJournal of Antimicrobial Chemotherapy, 1984
- The activity of miokamycin (MOM) against Chlamydia trachomatis and mycoplasmas in vitroJournal of Antimicrobial Chemotherapy, 1983